Potency Test for Vaccine Formulations
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 61/377,485, filed Aug 27, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,802,378 | Potency Test for Vaccine Formulations In force · High confidence | Intervet Inc. | In force | High confidence | ||
| US 9,599,607 | Potency Test for Vaccine Formulations In force · High confidence | Intervet Inc. | In force | High confidence | ||
| US 10,101,310 | Potency Test for Vaccine Formulations In force · High confidence | Intervet Inc. | In force | High confidence | ||
| US 10,852,286 | Ready to Use Porcine Vaccine In force · High confidence | Intervet Inc. | In force | High confidence | ||
| US 8,546,149 | Potency Test for Vaccine Formulations In force · High confidence | Intervet Inc. | In force | High confidence | ||
| Application 16/129,144 | Potency Test for Vaccine Formulations Abandoned Abandoned Feb 4, 2020 | Intervet Inc. | Abandoned | Abandoned Feb 4, 2020 |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Intervet Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.